| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT04537871 Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study · City of Hope Medical Center |
date change Primary completion pushed: 2026-06-30 -> 2027-05-25 |
| 2026-08-15 | NCT04537871 Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study · City of Hope Medical Center |
date change Completion pushed: 2026-06-30 -> 2027-05-25 |
| 2026-08-15 | NCT05150561 Muscle Dysfunction in Patients With Haematological Diseases · Rigshospitalet, Denmark |
date change Primary completion pushed: 2025-10-30 -> 2026-10-30 |
| 2026-08-15 | NCT05150561 Muscle Dysfunction in Patients With Haematological Diseases · Rigshospitalet, Denmark |
date change Completion pushed: 2026-05-01 -> 2026-12-01 |
| 2026-08-14 | NCT07469592 eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell… · University of Miami |
Recruitment opened |
| 2026-08-13 | NCT03680677 Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With… · Abramson Cancer Center at Penn Medicine |
date change Primary completion pushed: 2026-06-22 -> 2027-09-30 |
| 2026-08-13 | NCT03680677 Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With… · Abramson Cancer Center at Penn Medicine |
date change Completion pushed: 2026-11 -> 2027-11 |
| 2026-08-13 | NCT02942290 A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With… · AbbVie |
Trial completed |
| 2026-08-13 | NCT02942290 A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With… · AbbVie |
date change Primary completion moved earlier: 2027-01 -> 2026-04-15 |
| 2026-08-13 | NCT02942290 A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With… · AbbVie |
date change Completion moved earlier: 2027-01 -> 2026-04-15 |
| 2026-08-13 | NCT05444348 Compassionate Communication and Advance Care Planning to Improve End of Life Care in… · Christoffer Johansen |
date change Primary completion pushed: 2026-10-01 -> 2028-07-01 |
| 2026-08-13 | NCT05444348 Compassionate Communication and Advance Care Planning to Improve End of Life Care in… · Christoffer Johansen |
date change Completion pushed: 2026-10-01 -> 2028-07-01 |
| 2026-08-13 | NCT05968963 Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing… · University of Miami |
Trial completed |
| 2026-08-13 | NCT05968963 Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing… · University of Miami |
date change Completion moved earlier: 2026-06-01 -> 2025-06-04 |
| 2026-08-12 | NCT06661915 A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative… · National Cancer Institute (NCI) |
Recruitment resumed after suspension |
| 2026-08-12 | NCT06661915 A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative… · National Cancer Institute (NCI) |
Enrollment increased: 62 -> 78 participants |
| 2026-08-12 | NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid… · Sawa Ito, MD |
Primary endpoint(s) modified |
| 2026-08-12 | NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid… · Sawa Ito, MD |
Trial arms changed: 1 -> 2 |
| 2026-08-11 | NCT03744390 IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome · Groupe Francophone des Myelodysplasies |
date change Completion pushed: 2026-03-18 -> 2026-12-18 |
| 2026-08-11 | NCT06492707 DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse… · Fred Hutchinson Cancer Center |
critical Recruitment suspended |
| First Posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-08-13 | NCT07763054 Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia… | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine NEW | |
| 2026-08-12 | NCT07761533 PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS | Chaser Therapeutics, Inc. NEW | Phase 1/2 |
| 2026-08-12 | NCT07761390 DIEP-MDS for Risk Stratification of Flap Vascular Compromise and Failure in Breast… | Zhuliling NEW | |
| 2026-08-07 | NCT07753148 Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of… | Regeneron NEW | Phase 1 |
| 2026-08-06 | NCT07749976 GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL… | Vitruviae NEW | Phase 1/2 |
| 2026-07-23 | NCT07723703 Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and… | Amphista Therapeutics Ltd NEW | Phase 1 |
| 2026-07-23 | NCT07722988 A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating… | Kyntra Bio NEW | Phase 3 |
| 2026-07-22 | NCT07719348 A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid… | Servier NEW | Phase 1/2 |
| 2026-07-21 | NCT07717164 PRAISE-IR Versus CIBMTR Controls | Miltenyi Biomedicine GmbH NEW | |
| 2026-07-17 | NCT07710534 Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN | Virginia Commonwealth University NEW | Phase 2 |
| NCT ID | Title | Sponsor | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05991908 | Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating… | Shanghai Jiao Tong University School of Medicine | Recruiting |
| NCT04184505 | Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT) | Gruppo Italiano Malattie EMatologiche dell'Adulto | Recruiting |
| NCT06641414 | Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With… | Ascentage Pharma Group Inc. | Recruiting |
| NCT07396480 | Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan… | First Affiliated Hospital of Zhejiang University | Recruiting |
| NCT06499285 | A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk… | Takeda | Recruiting |
| NCT04064060 | A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other… | Celgene | Recruiting |
| NCT07422480 | A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low… | Takeda | Recruiting |
| NCT07702578 | A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic… | TScan Therapeutics, Inc. | Recruiting |
| NCT06465953 | Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With… | Institut de Recherches Internationales Servier | Recruiting |
| NCT05515029 | Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Active, Not Recruiting |
| NCT03839771 | A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and… | Stichting Hemato-Oncologie voor Volwassenen Nederland | Active, Not Recruiting |
| NCT03682536 | A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa… | Celgene | Active, Not Recruiting |
| NCT04027309 | A Study of Gilteritinib Versus Midostaurin in Combination With Induction and… | Stichting Hemato-Oncologie voor Volwassenen Nederland | Active, Not Recruiting |
| NCT05153226 | GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG | DKMS gemeinnützige GmbH | Active, Not Recruiting |
| NCT05674539 | Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic… | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Enrolling by Invitation |
| NCT03223961 | A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS | Groupe Francophone des Myelodysplasies | Active, Not Recruiting |
| NCT05883956 | A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and… | Otsuka Australia Pharmaceutical Pty Ltd | Active, Not Recruiting |
| NCT06927232 | AZA+Lus VS AZA Monotherapy in HR-MDS | Peking Union Medical College Hospital | Not Yet Recruiting |
| NCT02521493 | Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or… | Children's Oncology Group | Active, Not Recruiting |
| NCT05181592 | Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From… | GWT-TUD GmbH | Active, Not Recruiting |
| NCT05316701 | Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic… | Orca Biosystems, Inc. | Active, Not Recruiting |
| NCT04547049 | A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From… | First Affiliated Hospital of Zhejiang University | Active, Not Recruiting |
| NCT04401748 | Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change… | AbbVie | Active, Not Recruiting |
| NCT00843882 | Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic… | National Cancer Institute (NCI) | Active, Not Recruiting |
| NCT06045689 | A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants | Bristol-Myers Squibb | Active, Not Recruiting |